期刊文献+

ICU应激性溃疡预防药学管理模式的建立和效果评估 被引量:4

Establishment and effect evaluation of pharmaceutical management model for stress ulcer prophylaxis in ICU
原文传递
导出
摘要 目的建立药师主导的重症监护病房(ICU)应激性溃疡预防(SUP)药学管理模式,评估其在ICU实施中的效果。方法以药师为主导建立ICU-SUP药学管理模式,对该管理模式实施前后SUP的合理率、静脉给药转口服的比例、未及时停用SUP的比例、SUP药品费用及不良反应发生率进行比较。结果ICU-SUP药学管理模式实施后与实施前比较,SUP用药的合理率由50.84%升至93.87%(χ^(2)=101.048,P<0.05),其中无适应证用药的比例由15.13%降至5.19%(χ^(2)=11.838,P<0.05),有适应证未用药的比例由7.56%降至2.36%(χ^(2)=6.262,P<0.05),及时静脉给药转口服的比例由73.1%升至98.6%(χ^(2)=57.425,P<0.05),及时停止用药比例由68.9%升至94.8%(χ^(2)=49.107,P<0.05),SUP不适宜造成的药品费用支出由18206元降至2768元,共节约药品费用15438元。胃出血、腹泻及肺炎的发生率在ICU-SUP药学管理模式实施前后差异无统计学意义(χ^(2)=2.283,P>0.05;χ^(2)=0.463,P>0.05;χ^(2)=1.125,P>0.05)。结论在ICU建立药师主导的SUP药学管理模式可行、有效,可促进SUP用药的更加合理化。 Objective To establish a pharmacist-led pharmaceutical management model for stress ulcer prophylaxis(SUP)in intensive care unit(ICU)and evaluate its effect in ICU.Methods The pharmaceutical management model of SUP in ICU was established by the pharmacists as the leading role.The reasonable rate of SUP in ICU,ratio of intravenous to oral,prorate of timely SUP discontinuation,drug cost for prevention of stress ulcer,as well as incidence of adverse reactions before and after the implementation of the management model were compared.Results After the implementation of SUP pharmaceu⁃tical management model,the rational rate of SUP medication increased from 50.84%to 93.87%(χ^(2)=101.048,P<0.05),the rate of medication without indications decreased from 15.13%to 5.19%(χ^(2)=11.838,P<0.05),the proportion of medication without indications decreased from 7.56%to 2.36%(χ^(2)=6.262,P<0.05),the proportion of timely intravenous administration to oral administration increased from 73.1%to 98.6%(χ^(2)=57.425,P<0.05),the proportion of timely discontinuation in⁃creased from 68.9%to 94.8%(χ^(2)=49.107,P<0.05),the drug cost expenditure caused by inappropriate SUP decreased from 18206 yuan to 2768 yuan,with saving a total of 15438 yuan.There was no significant difference in the incidence of gastric bleeding,diarrhea and pneumonia before and after the implementation of SUP pharmaceutical management model(χ^(2)=2.283,P>0.05;χ^(2)=0.463,P>0.05;χ^(2)=1.125,P>0.05).Conclusion The pharmaceutical management model of stress ulcer led by pharmacists is feasible and effective,which can promote the rationalization of prevention and treatment of stress ulcer.
作者 韩芙蓉 李彤 宋智慧 徐姗姗 王昕 张弨 HAN Fu-rong;LI Tong;SONG Zhi-hui;XU Shan-shan;WANG Xin;ZHANG Chao(Department of Pharmacy,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China;Intensive Care Unit,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China)
出处 《临床药物治疗杂志》 2022年第11期40-43,共4页 Clinical Medication Journal
基金 北京药学会临床药学研究项目(2019-01-05)。
关键词 药学管理模式 应激性溃疡预防 重症监护病房 pharmaceutical management model stress ulcer prophylaxis ICU
  • 相关文献

参考文献2

二级参考文献49

  • 1李兆申.重视应激性溃疡的规范化防治[J].世界华人消化杂志,2005,13(22):2637-2639. 被引量:88
  • 2Bardou M, Quenot JP, Barkun A. Stress-related mucosal disease in the critically ill patient [ J 1. Nat Rev Gastroenterol Hepatol, 2015, 12(2) :9$-107.
  • 3Quenot JP, Thiery N, Barbar S. When should stress ulcer prophylaxis be used in the ICU? [J]. Curr Opin Crit Care, 2009, 15(2) :139-143.
  • 4Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group[J~. N Engl J Med, 1994, 330(6) :377-381.
  • 5Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients [ J ]. J Crit Care, 2005, 20 (1) :35-45.
  • 6ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998 [ J]. Am J Health Syst Pharm, 1999, 56(4) :347-379.
  • 7Spirt M J, Stanley S. Update on stress ulcer prophylaxis in critically ill patients [ J ]. Crit Care Nurse, 2006, 26 ( 1 ) : 18-20, 22 -25.
  • 8Marik PE, Vasu T, Hirani A, et al. Stress ulcer prophylaxis in the new millennium : a systematic review and meta-analysis [ J ]. Crit Care Med, 2010, 38 ( 11 ) :2222-2228.
  • 9Barkun AN, Bardou M, Pham CQ, et al. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis[ J]. Am J Gastroenterol, 2012, 107(4) :507-520.
  • 10Lin CC, I-Isu YL, Chung CS, et al. Stress ulcer prophylaxis in patients being weaned from the ventilator in a respiratory care center: a randomized control trial [ J/OL ]. J Formos Med Assoc, 2015 [ 2015-02-21 ]. http://www, jfma-online, corn/article/ S0929-6646( 14 )00297-6/fulltext. [ published online ahead of print February 9, 2015 ].

共引文献261

同被引文献28

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部